Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus

OBJECTIVE: To describe the clinical features of late-onset (≥50 years) neuromyelitis optica spectrum disorder (LO-NMOSD), to compare the outcome with that of early-onset (EO-NMOSD), and to identify predictors of disability. METHODS: A retrospective, multicenter study of 238 patients with NMOSD ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepulveda, Maria, Delgado-García, Guillermo, Blanco, Yolanda, Sola-Valls, Nuria, Martinez-Lapiscina, Elena H., Armangué, Thaís, Montejo, Carmen, Pulido-Valdeolivas, Irene, Martinez-Hernandez, Eugenia, Ariño, Helena, Escudero, Domingo, Ruiz-García, Raquel, Llufriu, Sara, Dalmau, Josep, Graus, Francesc, Saiz, Albert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745725/
https://www.ncbi.nlm.nih.gov/pubmed/31471461
http://dx.doi.org/10.1212/NXI.0000000000000607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745725/
https://www.ncbi.nlm.nih.gov/pubmed/31471461
http://dx.doi.org/10.1212/NXI.0000000000000607

Ejemplares similares